 It has been suggested that cholinesterase inhibitors ChEI, medications used for treatment of dementia, may improve motor function and walking gait performance. Since ChEI are known to improve attention, we hypothesized that ChEI will reduce falls risk in people with MCI by improving their gait velocity, improving their balance, and reducing their gait variability; a well-established risk factor for falls. 